China’s Harbour BioMed has launched a new biotech to develop bispecific antibodies focused on the holy grail of next-gen ...

Two years after first announcing the partnership, Boehringer Ingelheim and software firm Veeva Systems have launched ...

Japan's Ono Pharmaceutical is handing over $280 million upfront to acquire Ionis Pharmaceuticals’ phase 2-stage antisense ...

Roche is paying $1.65 billion in confirmed upfront fees to add to its burgeoning obesity pipelin | Roche is paying $1.65 ...

Funding granted to researchers by the National Institutes of Health (NIH) powered $94.58 billion in economic activity across ...

Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...

The drug in question, called vepdegestrant, is an oral PROteolysis TArgeting Chimera (PROTAC) ER degrader. The phase 3 study ...

Coherus BioSciences will see its workforce shrink once again as the result of the recently agreed sale of its Neulasta ...

Siemens Healthineers has obtained new clearances from the FDA for its photon-counting CT scanners, expanding its lineup with two machines aimed at bringing the imaging technology to a wid | Siemens ...

Daiichi Sankyo is stepping up its interest in RNA therapies, teaming with Nosis Biosciences to design drug candidates capable ...

Lila Sciences is looking to use $200 million in seed funding to develop advanced AI that can power fully autonomous research ...

Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous ...